Carve out of Tectrion for Bayers Currenta

Sektor(en)
Business Services / Industrie
Dealtyp
Restrukturierung / Unternehmensverkauf
Datum
Mai 2008
Beteiligte Länder
Germany

Kunde

Currenta GmbH, a Bayer and Lanxess joint venture operating several pharmaceutical/chemicals parks.

Transaktion

Carve out of underperforming unprofitable MRO business sales € approx. € 200 m into Tectrion GmbH.

Parteien

Projektleitung

  • Ervin Schellenberg

    Ervin Schellenberg

    Managing Partner Germany

What we did

Capitalmind developed a viable perimeter for the carve out from a potential future owner perspective, tested the prototype perimeter with investors in the market as exclusive corporate finance advisor. We performed valuation work on several scenarios providing our client with a solid decision-making basis.

About the deal

Carve out of underperforming unprofitable MRO business sales € approx. € 200 m into Tectrion GmbH.